Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15―25 years with and without serological evidence of previous exposure to HPV-16/18
- Author
- SZAREWSKI, A1 ; POPPE, W. A. J2 ; CASTELLSAGUE, X11 ; TEIXEIRA, J. C12 ; HEDRICK, J13 ; JAISAMRARN, U14 ; LIMSON, G15 ; GARLAND, S16 ; ROMANOWSKI, B17 ; AOKI, F. Y18 ; SCHWARZ, T. F19 ; BOSCH, F. X11 ; SKINNER, S. R3 ; HARPER, D. M20 ; HARDT, K21 ; ZAHAF, T21 ; DESCAMPS, D21 ; STRUYF, F21 ; LEHTINEN, M22 ; DUBIN, G23 ; WHEELER, C. M4 ; PAAVONEN, J5 ; NAUD, P6 ; SALMERON, J7 ; CHOW, S.-N8 ; APTER, D9 ; KITCHENER, H10
[1] Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom
[2] Department of Gynaecology, University Hospital KU Leuven Gasthuisberg, Leuven, Belgium
[3] Vaccines Trials Group, Telethon Institute for Child Health Research, Perth, WA and Sydney University Discipline of Paediatrics and Child Health, Children's Hospital Westmead, Sydney, NSW, Australia
[4] Departments of Pathology and Obstetrics and Gynecology, University of New Mexico Health Sciences Center, Albuquerque, NM, United States
[5] Department of Obstetrics and Gynaecology, University of Helsinki, Helsinki, Finland
[6] Department of Gynecology & Obstetrics, Federal University of Rio Grande do Sul - UFRGS/HCPA - Hospital de Clínicas de Porto Alegre, Brazil
[7] Unidad de Investigación Epidemiológica y en Servicios de Salud, Instituto Mexicano del Seguro Social, Morelos, Mexico
[8] Department of Obstetrics and Gynecology, College of Medicine and the Hospital, National Taiwan University, Taipei, Taiwan, Province of China
[9] Family Federation of Finland, Sexual Health Clinic, Helsinki, Finland
[10] Manchester Academic Health Science Centre, Central Manchester University Hospitals NHS Foundation Trust, St Mary's Hospital, Manchester, United Kingdom
[11] Institut Català d'Oncologia, L'Hospitalet de Llobregat, IDIBELL, CIBER-ESP, Catalonia, Spain
[12] Departamento de Tocoginecologia da Unicamp, University of Campinas, Campinas, Sao Paulo, Brazil
[13] Kentucky Pediatric and Adult Research, Bardstown, Cayman Islands
[14] Department of Obstetrics and Gynaecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
[15] College of Medicine, University of the Philippines, Philippine General Hospital, Makati Medical Centre, Makati City, Philippines
[16] Department of Microbiology and Infectious Diseases, The Royal Women's Hospital, Parkville/Department of Microbiology, The Royal Children's Hospital, Parkville/Murdoch Childrens Research Institute, Parkville/Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, Victoria, Australia
[17] Division of Infectious Diseases, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada
[18] Department of Medical Microbiology, University of Manitoba, Winnipeg, MB, Canada
[19] Central Laboratory and Vaccination Centre, Stiftung Juliusspital, Academic Teaching Hospital of the University of Wuerzburg, Wuerzburg, Germany
[20] Dartmouth Medical School, Lebanon NH, United States
[21] GlaxoSmithKline Biologicals, Wavre, Belgium
[22] University of Tampere, School of Public Health, Tampere, Finland
[23] GlaxoSmithKline Biologicals, King of Prussia, Panama
HPV PATRICIA Study Group - Source
International journal of cancer (Print). = Journal international du cancer. 2012, Vol 131, Num 1, pp 106-116, 11 p ; ref : 27 ref
- CODEN
- IJCNAW
- ISSN
- 0020-7136
- Scientific domain
- Medical oncology
- Publisher
- Wiley-Blackwell, Hoboken, NJ
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- human papillomavirus vaccines human papillomavirus-16 human papillomavirus-18 previous exposure vaccine efficacy against human papillomavirus-16/18
- Keyword (fr)
- Adulte Cancérologie Efficacité traitement Exposition Femelle Femme Homme Papillomavirus humain 16 Papillomavirus humain 18 Sérologie Vaccin Virose Infection Papillomavirus humain Papillomavirus Papovaviridae Virus
- Keyword (en)
- Adult Cancerology Treatment efficiency Exposure Female Woman Human Human papillomavirus 16 Human papillomavirus 18 Serology Vaccine Viral disease Infection Human papillomavirus Papillomavirus Papovaviridae Virus
- Keyword (es)
- Adulto Cancerología Eficacia tratamiento Exposición Hembra Mujer Hombre Human papillomavirus 16 Human papillomavirus 18 Serología Vacuna Virosis Infección Human papillomavirus Papillomavirus Papovaviridae Virus
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05C Viral diseases
- Discipline
- Infectious pathology Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 25905726
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1002/ijc.26362 
https://dx.doi.org/10.1002/ijc.26362
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/ijc.26362\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:172:\"Efficacy of the human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine in women aged 15\u201525 years with and without serological evidence of previous exposure to HPV-16\/18\";s:9:\"\u0000*\u0000jtitle\";s:39:\"International journal of cancer (Print)\";s:9:\"\u0000*\u0000stitle\";s:22:\"Int. j. cancer (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:3:\"131\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"106\";s:8:\"\u0000*\u0000epage\";s:3:\"116\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0020-7136\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"SZAREWSKI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:26:{i:0;s:14:\"POPPE, W. A. J\";i:1;s:15:\"CASTELLSAGUE, X\";i:2;s:14:\"TEIXEIRA, J. C\";i:3;s:10:\"HEDRICK, J\";i:4;s:13:\"JAISAMRARN, U\";i:5;s:9:\"LIMSON, G\";i:6;s:10:\"GARLAND, S\";i:7;s:13:\"ROMANOWSKI, B\";i:8;s:10:\"AOKI, F. Y\";i:9;s:13:\"SCHWARZ, T. F\";i:10;s:11:\"BOSCH, F. X\";i:11;s:13:\"SKINNER, S. R\";i:12;s:12:\"HARPER, D. M\";i:13;s:8:\"HARDT, K\";i:14;s:8:\"ZAHAF, T\";i:15;s:11:\"DESCAMPS, D\";i:16;s:9:\"STRUYF, F\";i:17;s:11:\"LEHTINEN, M\";i:18;s:8:\"DUBIN, G\";i:19;s:13:\"WHEELER, C. M\";i:20;s:11:\"PAAVONEN, J\";i:21;s:7:\"NAUD, P\";i:22;s:11:\"SALMERON, J\";i:23;s:10:\"CHOW, S.-N\";i:24;s:8:\"APTER, D\";i:25;s:12:\"KITCHENER, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"IJCNAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:172:\"Efficacy of the human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine in women aged 15\u201525 years with and without serological evidence of previous exposure to HPV-16\/18\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:15:\"Wiley-Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/ijc.26362\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:172:\"Efficacy of the human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine in women aged 15\u201525 years with and without serological evidence of previous exposure to HPV-16\/18\";s:9:\"\u0000*\u0000jtitle\";s:39:\"International journal of cancer (Print)\";s:9:\"\u0000*\u0000stitle\";s:22:\"Int. j. cancer (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:3:\"131\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"106\";s:8:\"\u0000*\u0000epage\";s:3:\"116\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0020-7136\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"SZAREWSKI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:26:{i:0;s:14:\"POPPE, W. A. J\";i:1;s:15:\"CASTELLSAGUE, X\";i:2;s:14:\"TEIXEIRA, J. C\";i:3;s:10:\"HEDRICK, J\";i:4;s:13:\"JAISAMRARN, U\";i:5;s:9:\"LIMSON, G\";i:6;s:10:\"GARLAND, S\";i:7;s:13:\"ROMANOWSKI, B\";i:8;s:10:\"AOKI, F. Y\";i:9;s:13:\"SCHWARZ, T. F\";i:10;s:11:\"BOSCH, F. X\";i:11;s:13:\"SKINNER, S. R\";i:12;s:12:\"HARPER, D. M\";i:13;s:8:\"HARDT, K\";i:14;s:8:\"ZAHAF, T\";i:15;s:11:\"DESCAMPS, D\";i:16;s:9:\"STRUYF, F\";i:17;s:11:\"LEHTINEN, M\";i:18;s:8:\"DUBIN, G\";i:19;s:13:\"WHEELER, C. M\";i:20;s:11:\"PAAVONEN, J\";i:21;s:7:\"NAUD, P\";i:22;s:11:\"SALMERON, J\";i:23;s:10:\"CHOW, S.-N\";i:24;s:8:\"APTER, D\";i:25;s:12:\"KITCHENER, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"IJCNAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:172:\"Efficacy of the human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine in women aged 15\u201525 years with and without serological evidence of previous exposure to HPV-16\/18\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:15:\"Wiley-Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/ijc.26362\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/ijc.26362\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:172:\"Efficacy of the human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine in women aged 15\u201525 years with and without serological evidence of previous exposure to HPV-16\/18\";s:9:\"\u0000*\u0000jtitle\";s:39:\"International journal of cancer (Print)\";s:9:\"\u0000*\u0000stitle\";s:22:\"Int. j. cancer (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:3:\"131\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"106\";s:8:\"\u0000*\u0000epage\";s:3:\"116\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0020-7136\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"SZAREWSKI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:26:{i:0;s:14:\"POPPE, W. A. J\";i:1;s:15:\"CASTELLSAGUE, X\";i:2;s:14:\"TEIXEIRA, J. C\";i:3;s:10:\"HEDRICK, J\";i:4;s:13:\"JAISAMRARN, U\";i:5;s:9:\"LIMSON, G\";i:6;s:10:\"GARLAND, S\";i:7;s:13:\"ROMANOWSKI, B\";i:8;s:10:\"AOKI, F. Y\";i:9;s:13:\"SCHWARZ, T. F\";i:10;s:11:\"BOSCH, F. X\";i:11;s:13:\"SKINNER, S. R\";i:12;s:12:\"HARPER, D. M\";i:13;s:8:\"HARDT, K\";i:14;s:8:\"ZAHAF, T\";i:15;s:11:\"DESCAMPS, D\";i:16;s:9:\"STRUYF, F\";i:17;s:11:\"LEHTINEN, M\";i:18;s:8:\"DUBIN, G\";i:19;s:13:\"WHEELER, C. M\";i:20;s:11:\"PAAVONEN, J\";i:21;s:7:\"NAUD, P\";i:22;s:11:\"SALMERON, J\";i:23;s:10:\"CHOW, S.-N\";i:24;s:8:\"APTER, D\";i:25;s:12:\"KITCHENER, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"IJCNAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:172:\"Efficacy of the human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine in women aged 15\u201525 years with and without serological evidence of previous exposure to HPV-16\/18\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:15:\"Wiley-Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/ijc.26362\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:172:\"Efficacy of the human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine in women aged 15\u201525 years with and without serological evidence of previous exposure to HPV-16\/18\";s:9:\"\u0000*\u0000jtitle\";s:39:\"International journal of cancer (Print)\";s:9:\"\u0000*\u0000stitle\";s:22:\"Int. j. cancer (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:3:\"131\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"106\";s:8:\"\u0000*\u0000epage\";s:3:\"116\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0020-7136\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"SZAREWSKI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:26:{i:0;s:14:\"POPPE, W. A. J\";i:1;s:15:\"CASTELLSAGUE, X\";i:2;s:14:\"TEIXEIRA, J. C\";i:3;s:10:\"HEDRICK, J\";i:4;s:13:\"JAISAMRARN, U\";i:5;s:9:\"LIMSON, G\";i:6;s:10:\"GARLAND, S\";i:7;s:13:\"ROMANOWSKI, B\";i:8;s:10:\"AOKI, F. Y\";i:9;s:13:\"SCHWARZ, T. F\";i:10;s:11:\"BOSCH, F. X\";i:11;s:13:\"SKINNER, S. R\";i:12;s:12:\"HARPER, D. M\";i:13;s:8:\"HARDT, K\";i:14;s:8:\"ZAHAF, T\";i:15;s:11:\"DESCAMPS, D\";i:16;s:9:\"STRUYF, F\";i:17;s:11:\"LEHTINEN, M\";i:18;s:8:\"DUBIN, G\";i:19;s:13:\"WHEELER, C. M\";i:20;s:11:\"PAAVONEN, J\";i:21;s:7:\"NAUD, P\";i:22;s:11:\"SALMERON, J\";i:23;s:10:\"CHOW, S.-N\";i:24;s:8:\"APTER, D\";i:25;s:12:\"KITCHENER, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"IJCNAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:172:\"Efficacy of the human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine in women aged 15\u201525 years with and without serological evidence of previous exposure to HPV-16\/18\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:15:\"Wiley-Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/ijc.26362\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:172:\"Efficacy of the human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine in women aged 15\u201525 years with and without serological evidence of previous exposure to HPV-16\/18\";s:9:\"\u0000*\u0000jtitle\";s:39:\"International journal of cancer (Print)\";s:9:\"\u0000*\u0000stitle\";s:22:\"Int. j. cancer (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:3:\"131\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"106\";s:8:\"\u0000*\u0000epage\";s:3:\"116\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0020-7136\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"SZAREWSKI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:26:{i:0;s:14:\"POPPE, W. A. J\";i:1;s:15:\"CASTELLSAGUE, X\";i:2;s:14:\"TEIXEIRA, J. C\";i:3;s:10:\"HEDRICK, J\";i:4;s:13:\"JAISAMRARN, U\";i:5;s:9:\"LIMSON, G\";i:6;s:10:\"GARLAND, S\";i:7;s:13:\"ROMANOWSKI, B\";i:8;s:10:\"AOKI, F. Y\";i:9;s:13:\"SCHWARZ, T. F\";i:10;s:11:\"BOSCH, F. X\";i:11;s:13:\"SKINNER, S. R\";i:12;s:12:\"HARPER, D. M\";i:13;s:8:\"HARDT, K\";i:14;s:8:\"ZAHAF, T\";i:15;s:11:\"DESCAMPS, D\";i:16;s:9:\"STRUYF, F\";i:17;s:11:\"LEHTINEN, M\";i:18;s:8:\"DUBIN, G\";i:19;s:13:\"WHEELER, C. M\";i:20;s:11:\"PAAVONEN, J\";i:21;s:7:\"NAUD, P\";i:22;s:11:\"SALMERON, J\";i:23;s:10:\"CHOW, S.-N\";i:24;s:8:\"APTER, D\";i:25;s:12:\"KITCHENER, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"IJCNAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:172:\"Efficacy of the human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine in women aged 15\u201525 years with and without serological evidence of previous exposure to HPV-16\/18\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:15:\"Wiley-Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
